- $121.93bn
- $140.83bn
- £32.67bn
- 98
- 63
- 99
- 99
REG - Allianz Glbl Inv - Top 10 Holdings
AnnouncementREG - GlaxoSmithKline PLC - Total Voting Rights
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - ViiV Healthcare announces FDA approval of Apretude
AnnouncementREG - GlaxoSmithKline PLC - Consumer Healthcare Chair Designate appointed
AnnouncementREG - GlaxoSmithKline PLC - Xevudy approved in Europe to treat COVID-19
AnnouncementREG - GlaxoSmithKline PLC - GSK/Sanofi COVID-19 vaccine booster & Ph3 update
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG-GlaxoSmithKline plc: Total Voting Rights
AnnouncementREG - JPMorgan Inv. Trusts - Ten Largest Investments
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSK Capital PLC - Publication of a Prospectus
AnnouncementREG - GlaxoSmithKline PLC - Medicago/GSK COVID-19 vaccine positive Ph3 data
AnnouncementREG - GlaxoSmithKline PLC - Sotrovimab retains its activity vs Omicron variant
AnnouncementREG - Allianz Glbl Inv - Top 10 Holdings
AnnouncementREG - GlaxoSmithKline PLC - Sotrovimab retains its activity vs Omicron variant
AnnouncementREG-GlaxoSmithKline plc: Total Voting Rights
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
Announcement